Drugs Made In America Acquisition II Corp. (DMII)
NASDAQ:DMII
Want to see DMII full AI Analyst Report?
Comparison Results
M3-Brigade Acquisition V Corp. Class A
$10.91
$388.13M
0.05
3.35%
―
Oaktree Acquisition Corp. III Life Sciences Class A
$10.64
$262.18M
36.43
2.55%
―
Translational Development Acquisition Corp.
$10.61
$233.10M
34.23
4.21%
―
Drugs Made In America Acquisition Corp.
$10.53
$257.34M
30.58
4.64%
―
Archimedes Tech SPAC Partners II Corporation
$10.45
$336.73M
35.11
13.01%
―
Performance Comparison
DMII
Drugs Made In America Acquisition II Corp.
10.06
0.18
1.82%
MBAV
M3-Brigade Acquisition V Corp. Class A
10.80
-0.53
-4.68%
OACC
Oaktree Acquisition Corp. III Life Sciences Class A
10.67
0.26
2.55%
TDAC
Translational Development Acquisition Corp.
10.64
0.45
4.42%
DMAA
Drugs Made In America Acquisition Corp.
10.60
0.48
4.74%
ATII
Archimedes Tech SPAC Partners II Corporation
11.38
1.29
12.78%